A Retrospective Analysis of Three Antiviral Regimens of Peramivir in the Treatment of Severe Influenza A with Primary Viral Pneumonia

Table 3

Clinical efficacy of three groups.

Item	Group A ()	Group B ()	value	Group A ()	Group C ()	value
	Mean ± SD	Mean ± SD		Mean ± SD	Mean ± SD
Duration of virus nucleic acid positivity, days	6.13 ± 2.06	6.53 ± 2.72	0.19	6.13 ± 2.06	6.10 ± 1.37	0.65
Remission time of clinical symptoms, days	8.06 ± 2.73	7.94 ± 2.89	0.47	8.06 ± 2.73	7.67 ± 1.58	0.80
Time to fever alleviation, hours	28.89 ± 16.37	26.93 ± 12.04	0.74	28.89 ± 16.37	27.20 ± 8.87	0.96
Time to cough alleviation, hours	72.00 ± 31.45	69.43 ± 34.99	0.90	72.00 ± 31.45	70.00 ± 42.76	0.99